Clinical Trials in New York

Showing 19021-19040 of 22,668 trials

Community Primary Care Providers to Implement and Disseminate Cancer Prevention Interventions for Latino Populations

NCT01803750

The purpose of this study is to understand primary care provider's knowledge, attitudes, and barriers to promoting evidence-based cancer screening and prevention practices for physicians with large Latino patient populations. The investigators will ask providers information on cancer screening and prevention practices by conducting one-on-one interviews. In addition, they would like to develop a committee of community providers to help design and implement cancer screening and prevention programs specifically for Latino patients based on the interview findings.

For New York State Registered Family Practitioners and Internal Medicine Physicians

Memorial Sloan Kettering Cancer Center3 participantsStarted Feb 2013

New York, New York, United States

COMPLETEDPhase 4< 1 mile

Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo

NCT00334048

Antidepressant medicines sometimes cause sexual side effects. The purpose of this study is to determine whether the sexual dysfunction sometimes caused by selective serotonin reuptake inhibitor (SSRI) antidepressant medications can be reversed by treatment with Requip (ropinirole), a medicine which is used to treat Parkinson's Disease and restless leg syndrome.

Sexual Dysfunction

St. Luke's-Roosevelt Hospital Center9 participantsStarted Jun 2006

New York, New York, United States

Community Primary Care Providers to Implement and Disseminate Cancer Prevention Interventions for Latino Populations

Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo

Find Trials by Condition in New York

Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula

iCAT for Recurrent/Refractory/HR Solid Tumors

A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial

Physician-Patient Communication About Breast Cancer-Related Internet Information and Its Effect on Patient Satisfaction and Anxiety

Single Arm Post-marketing Study of SC20 Colonoscope

hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects

A Study to Assess the Safety and Pharmacokinetics of a Single Intravenous Administration of CNTO 328 Derived From 2 Different Cell Lines in Healthy Participants

Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients

Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer